CEO Mark Dunkerley said lower fuel costs and strong demand propelled the strong quarterly results. » Read More
CNBC's Steve Liesman and Scott Minerd, Guggenheim Partners Global Chief Investment Officer and Chairman of Investments, break down the Federal Reserve policy statement leaving rates unchanged and look at the possibility of a move in June.
CNBC's Dominic Chu looks at the market reaction to the Federal Reserve statement.
CNBC's Hampton Pearson reports the decision out from the Federal Reserve. The FOMC says that economic activity appears to have slowed, but that the economy will continue to expand at a moderate pace.
CNBC's Hampton Pearson reports the decision out from the Federal Reserve.
David Kelly, JPMorgan Funds Chief Global Strategist, and Bob Doll, Nuveen Asset Management Chief Equity Strategist and Portfolio Manager, look ahead at the Federal Reserve's policy decision.
Benjamin Mayo, iOS developer and writer for 9t05 Mac, and CNBC.com editor Ari Levy talk about Apple's product cycle and how the tech giant can continue to grow and innovate.
Jamie Cox, Harris Financial Group Managing Partner, and Art Hogan, Wunderlich Securities Chief Market Strategist, discuss rotation in the markets and how to approach investing in this market.
CNBC's Michelle Caruso-Cabrera reports from Iran about the realities of doing business in the country after the lifting of the nuclear sanctions.
Scott Mather, PIMCO Chief Investment Officer U.S. Core Strategies, looks ahead to the Federal Reserve and Bank of Japan policy statements.
Matt Maley, Miller Tabak & Co. Managing Director and Equity Strategist, looks at the technicals of Apple stock and how to approach it. Rob Hall of JPMorgan also weighs in.
Rod Hall, Analyst at JPMorgan, and Jason Ware, Albion Financial Chief Investment Officer, discuss Apple's dismal earnings release and how to approach investing in the tech giant.
A very low number of students are ready for college, and it's getting worse.
Brian Sullivan says Apple's real problem is that it hasn't produced a truly new product in six years.
U.S. sovereign bond prices rose on Wednesday following the Federal Reserve’s April rate decision.
Homebuyers stepped up their purchases in March, signing contracts to buy existing homes at the highest pace in nearly a year.
A daily morning look at the financial stories you need to know to start the day.
Janus Capital reported earnings on Tuesday and the company's CEO joined CNBC to discuss business strategy, Bill Gross and ETFs.
The Vanguard founder said investors shouldn't expect the next decade's returns to be as stellar as in the past.
Ezekiel Emanuel, Chair of Medical Ethics & Health Policy at the University of Pennsylvania, and Darcy Olsen, Goldwater Institute President, discuss the ethical arguments around whether patients should have the right to try potentially risky medical trials and therapies.
Liisa Bayko, JMP Securities Biotech Analyst and Managing Director, discusses the FDA's rejection of fast-track approval of Sarepta's Duchenne muscular dystrophy drug.